Rights and permissions
About this article
Cite this article
Tamoxifen plus RT: sequencing not vital in breast cancer. Inpharma Wkly. 1480, 9 (2005). https://doi.org/10.2165/00128413-200514800-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200514800-00020